SERA PROGNOSTICS, INC. — Director's Dealing 2022

Feb 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2022-01-28

Reporting Person: Foley Michael R (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-28	Stock Option (right to buy)	$6.59	A	276000	Acquired	2032-01-28	Class A Common Stock (276000.0)	Direct

Footnotes

F1: These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is January 28, 2022, and 1/36 of the remaining amount vests in monthly installments for three years thereafter.